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A ‘good’ ethical review: audit and 
professionalism in research ethics  
 
Rachel Douglas-Jones 
 
How does one conduct, measure and record a ‘good’ ethical review of biomedical research? 
To what extent do ethics committees invoke professionalism in researchers and in themselves, 
and to what extent do they see competence as adherence to a set of standard operating 
procedures for ethical review? Drawing on ethno- graphic fieldwork with the Forum of Ethics 
Review Committees of Asia and the Pacific (FERCAP), a capacity-building NGO that runs 
ethics committee trainings and reviews in the Asia Pacific region, I develop an analysis of 
ethical review and its effects. I focus on a ‘second-order audit’ run by FERCAP, which 
recognises committees according to a set of standards that are designed to render ‘local’ 
committees internationally legible. The article adds to a growing comparative literature that 
expands studies of audit-like measuring and disciplining activities beyond western contexts 
and enriches readings of ‘ethics’. I begin and end with a reflection on the ethical effects of a 
measurement practice that takes ethics itself as its object.  
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Introduction  
[53] 1What are the ethical effects of a measurement practice that takes ethics as 
its object? To address this question I explore the assessment of biomedical 
research ethics commit- tees conduct in five Asian countries by a regional 
NGO.1 I pay particular attention to the relationship between audit processes and 
the idea of being a ‘good professional’ (Pels 2000; Exworthy and Halford 
1999). This was a central question to members of the organisation I worked 
with: how does one conduct, measure and record a ‘good’ ethical review of 
biomedical research? If one is seeking to foster ethical behaviour, they ask, 
should one look to audit-based practices, or attempt to shape people’s 
sensibilities and actions?  
These questions circulated during 2009–10, as the Forum of Ethics Review 
Com- mittees of Asia and the Pacific (FERCAP) was working to train and 
evaluate ethics re- view committees.2 My ethnographic work with FERCAP 
explored how practices of ethical review are being taken up in government and 
private hospitals and universities across the region. Working with over 100 
institutions and 300 individual members, including doctors, academics and 
research administrators, FERCAP was the most successful of five arms of the 
Strategic Initiative in Developing Capacity in Ethical Review (SIDCER), 
funded in part by the World Health Organization’s Tropical Disease Research 
section. Operating from a two-person office based at Thammasat University, 
Bangkok, FERCAP’s main activities involve travel across the region to 
conduct training, [54] and their key activity of surveying and recognising (not 
auditing or accrediting) ethics review committees in Asia and the Pacific 
region. Through this sur- veying work, they bring standards to bear on what 
constitutes a ‘good ethical review’ and, alongside a process-oriented definition 
of doing ethics, give attention to the pos- sibilities for an ethics of individual 
reform. But how they carry out their auditing work has characteristics that set it 
apart from the well-known effects and tactics of audit (Strathern 2000). It is 
their approach that interests me here, since it imbues the measure- ment of 
‘ethics’ [ethical review] with certain ethics of practice [reviewing ethical 
review].  
Building on Power’s 1994 work and essays collected in Audit cultures 
(Strathern 2000), scholars have traced how, as audit-based mechanisms shift 
‘domains’, they re-work relationships, responsibilities, accountabilities and 
forms of governance (Strathern 1992). Two recent examples demonstrate these 
technologies of governance and our theorising about them. Merry (2011) has 
examined indicators as a mode of ‘measuring the world’, characteristic of the 
‘dissemination of the corporate form of thinking and governance into broader 
social spheres’ and the need for critical analysis ‘in the contest over who counts 	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and what information counts’ (S83, S85). In a similar way, STS scholars 
Jensen and Winthereik (2013) have used their study of Danish aid auditors to 
advance understandings of how audit regimes ‘loop’ in upon and come to apply 
to those who administer them: auditors, too, are now subject to audit (cf. Power 
1994: 7–8).  
This article adds to these debates by exploring how ethics operates as a form of 
governance: it sketches the relationship between the measurement mechanisms 
of FERCAP’s activities and the way committee members talk about their roles. 
However, if ethical review of biomedical research is a kind of first-order audit, 
FERCAP’s work in reviewing and ‘recognising’ ethics committees’ activities is 
a second-order audit. It fulfils Power’s prediction that the logic of audit may be 
to ‘replace the monitoring of quality [ethical review] with the monitoring of 
systems to monitor quality [the recog- nition program]’ (1994: 6). FERCAP’s 
activities at the intersection between ethics and audit constitute a form of 
‘mutual reference point’ (Strathern 2000: 282), whereby a codified ethics 
‘could be thought of as an enlarged or magnified version of audit: it spe- 
cifically relates ‘good practice’ to individual conduct’ (Strathern 2000: 292). 
Here, how- ever, the conduct is that of the collective, the committee, whose 
biomedical members collapse a distinction between a community whose 
individual conduct is being checked (biomedical researchers) and those who do 
the checking (committee members). Fur- thermore, their ‘good practice’ 
becomes a question of doing ethics ethically, a topic ex- plored in Peter Pels’ 
work (1999, 2000). In his interrogation of the specific interface of ethics and 
anthropology, he traces in broad strokes a common history for a romantic 
ethics and a utilitarian economics, identifying as the outcomes the poles of 
audit and professionalism between which a ‘liberal pendulum’ swings (2000: 
148). Using Campbell’s (1987) revision of Weber’s Protestant ethic, Pels 
identifies at one pole of his ‘liberal pendulum’ a romantic ethic tied to feeling 
and liberated by the imagination. At the other pole is a utilitarian and 
productivity-oriented ethic, in which economic calculation demonstrates moral 
excellence (Pels 2000: 147–8). In what follows, I attempt to divorce Pels’ rich 
argument from its investment in the anthropological pro- fession and turn it in 
on the governance of biomedicine through ethical review. FERCAP’s work 
exists because of ethical review processes, a (utilitarian) mode of governing 
biomedical research rooted in distrust of the medical professional [55] 
(romantic). This tension he identifies between these utilitarian and romantic 
poles is ev- ident in the question FERCAP asks itself: where should one look 
for governance of biomedical research – professional sensibilities or 
measurable processes? That it has be- come such a question is indicative of the 
generation of an intriguing dichotomy. If Pels’ liberal pendulum is suspended, 
in this case, between a romantic professionalism and utilitarian audit, what are 
the different meanings of ‘ethics’ in effecting these different strategies of 
governance?  
Pels’s groundwork allows me to situate the work of FERCAP in a context 
where ‘ethics’ has moved from being in the custody of the medical profession, 
to being some- thing that is done ‘to’ medical professionals, through 
institutions such as the ethics committee. It is furthermore something 
researchers can ‘get’, or receive. The first sec- tion of the following attends 
briefly to the way in which bioethical histories of the USA are told in 
FERCAP’s Asian trainings, demonstrating how sites of biomedical re- search 
are linked now not only by experimental practices, but also by particular forms 
of ‘ethics practice’. I build here on the work of the UK historian Duncan 
Wilson, whose research showed how ethics review committees separated ethics 
from profes- sions during the burgeoning era of audit. The second section 
examines the contempo- rary effects of that shift through FERCAP’s activities, 
showing how their work across Asia operates as a second-order audit, 
reviewing and ‘recognising’ committees’ prac- tices of review. In training and 
reviewing ethics review practices, we see the ordering and auditing work of 
governance techniques beyond the nation state. The third section returns 
ethnographically to the relationship between the audited and the 
professionalised self, to describe ethics as a technology of governance that 
simulta- neously engages with, and matures out of, the limits and 
disappointments of ethical review as a pre-emptive audit. I suggest that in 
FERCAP’s practices we find not only new calculations of audit practices, but 
also configurations of familiar states of responsibilisation.  
Profession to audit  
Collectively, the papers assembled here observe that audit regimes increasingly 
oper- ate beyond the nation state (Shore and Wright, this issue). FERCAP’s 
work is trans- national, and my own fieldwork as an observer and trainee 
surveyor took place in five of the ten Asian countries in which they work: Sri 
Lanka, Thailand, Taiwan, the Philippines and mainland China. In this section, I 
introduce the landscape of transnational research ethics as described to me by 
two women who coordinate FERCAP’s work across these different settings. 
Their accounts illustrate the take up of Euro-American histories of bioethics, as 
well as practices of research ethics. My argument draws additionally on 
material gathered from attending workshops and trainings on Good Clinical 
Practice and Human Subject Research Protection, and participant observation 
in the review of ethics committee work – The Survey – in each of my five 
fieldwork countries. While nations, climates and legislation changed between 
sites, the core review team remained constant: committees of around 10 people, 
formally required to be of equal gender and prescribed profession. FERCAP’s 
activities are partly a response to the growth of clinical trials through the 1990s 
and 2000s, especially those that run the same trial protocol in several places at 
once. The spread of standardised biomedical research infrastructure and 
techniques [56] (Rosemann 2012; Petryna 2009; Sariola and Simpson 2012) 
has also brought demands that research protocols be reviewed ‘locally’. When 
FERCAP presents its programme of ‘recognition’ to prospective committees, it 
describes a world in which trials are composed from research done in different 
parts of the world. ‘The same trial being done in Asia, we see it being done in 
Africa, in the West.’ ‘No matter where,’ they say, ‘the concern is about quality 
of research.’ At a cancer centre in southern China, towards the end of my 
research, I listened as a FERCAP surveyor explained:  
Basically we work in an environment where clinical trials are globalizing. In 
your cancer centre, you’re doing some of the global trials. I have visited many 
coun- tries in Asia. Cancer clinical trials are most frequent and popular, and I 
see the same design being adopted, one protocol done in different countries all 
at the same time.  
This expansion of multi-sited research has led to multi-sited review processes. 
Just as the scientific data of multi-sited trials has now become integrated into 
what it means to produce ‘good’ science (Douglas-Jones 2012a), so too has 
ethical review. ‘Good sci- ence’ is based on both reliable and ethical data.3 For 
more than a decade, international collaborative trials have meant that capacity-
building activities in ethical review have been going on all over the world 
(Eckstein 2004). They aim at establishing and training committees to perform 
an ethical review of a research proposal. More recent docu- ments produced by 
the European Medical Association put the need for ‘local’ ethics committees 
more strongly, insisting that a local ethics committee is a prerequisite to a 
clinical trial taking place at all (EMA 2012). But what drives these demands? 
The practices of ethical review remain a concern of clinical trial sponsors, for 
whom the ethics committee ‘is an entity over which sponsor auditors have no 
jurisdiction’, mean- ing that ‘what is beyond the documentation ... is a 
complete unknown for the sponsor and their auditors’ (Hamadian and Johansen 
2010: 17). FERCAP’s activities offer a thorough measure of competence for 
external or distant parties relying on the commit- tee’s review (cf. Espeland and 
Sauder 2009).  
Those involved in FERCAP’s activities make their own arguments for local 
capac- ity building in ethical review: Juntra Karbwang, a UK-trained Thai 
researcher and at that point WHO employee – one of my key interlocutors – is 
the coordinator and a co-founder of the Strategic Initiative in Developing 
Capacity in Ethical Review (SIDCER). The initiative was established to help 
countries help themselves as they es- tablish biomedical research, a process 
that, in good audit tradition, entails ‘helping (monitoring) people help 
(monitor) themselves’ (Strathern 2000: 4). Speaking about the initiative and its 
intended effects, Juntra commented that ‘review has to come from within the 
country. Rather than use England ... or Geneva, why not harness capacity?’ She 
leverages her position as an experienced Thai researcher against her job and 
col- leagues in the WHO when speaking about the inadequacy of inequalities in 
review ca- pacity: ‘Why use Geneva [as a reviewer]?’, she asks; ‘the power 
stays with them’. At meetings with the WHO in Geneva she questions the 
assumption that other countries ‘don’t know how to do review’ and asserts that 
they do. The ‘review of review’ process she has been instrumental in 
establishing provides the evidence she needs for this claim.  
[57] Part of my work in understanding FERCAP’s activities has been to trace 
concep- tual and national legacies in the ideas being discussed and practices 
being taught: tech- niques of accountability achieve efficacy in different ways, 
they gain different purchases when employed in new places (Kipnis 2008), and 
they carry parts of their histories with them. One story regularly told in 
trainings I attended on Human Subject Protection was of the infamous 
Tuskegee syphilis study in the USA (Reverby 2009). The New York Times 
first broke this particular story on 29 July 1972, to huge uproar. It revealed that 
even though an effective cure for syphilis – penicillin – was discovered during 
the course of the 40-year-long study, researchers did not treat the participating 
patients. In the aftermath of Tuskegee it was clear to the American public that 
‘funda- mental questions needed to be asked about the nature of authority 
assigned to physi- cians’ (Wilson 2011: 199). Wilson highlights the comments 
of Yale-based lawyer Jay Katz, who used Tuskegee to claim that ‘doctors 
possessed no unique expertise that jus- tified making them the sole arbiters of 
medical ethics’; his suggested remedy was ‘more active participation of non-
scientists in research decisions’ (Katz 1972a: 606 and Katz 1972b: 1, cited in 
Wilson 2011: 199). Arguments such as this, Wilson suggests, led to a profound 
shift in the locus of governance over biomedical research: ethics review 
committees, regarded as external to the research, were seen as better placed to 
assess the ethics of research than doctors. This ‘profound shift’ had been 
building for decades (Stark 2012; Wilson 2012), not least since the Nuremberg 
Trials after World War II, but a new ‘exteriority’, to use Wilson’s language, 
marked the burgeoning audits of the 1980s. External review of biomedical 
research has today taken deep root alongside other audit-based activities that 
began to flourish in that decade. Sociologist Laura Stark argues that, in the 
USA, ‘the moral authority to decide how to treat research par- ticipants was 
relocated from professions to the state and reinvested in procedures rather than 
ethics principles’ (2012: 7).  
These ‘procedures’ are the focus of FERCAP’s work, although what they do is 
not based in state policies, as in Stark’s work, and is not contained by national 
borders. Their focus is on building ‘capacity’ in ethical review across the Asian 
region. The organisation’s coordinator, Cristina, commented that her approach:  
has made it possible to operationalize the basic ethical principles of autonomy, 
beneficence, and justice in the review of health research and translate them into 
tools, such as checklists and assessment forms to assist the committee members 
in reviewing protocols, consent forms, and related documents. (Torres 2011: 
49, emphasis added)  
While FERCAP’s trainings are peppered with bioethics stories – a litany of 
histor- ical examples I became familiar with over the course of research – the 
trainings also observe and police a distinction between bioethics and research 
ethics. Members of FERCAP described their encounters with bioethics as 
‘philosophical’ and ‘discussion based’ and they did not count bioethics classes 
in ‘moral dilemmas’ as ‘skills’, since res- olutions were not the priority. This 
contrasted with an emphasis on procedures in FERCAP’s approach to research 
ethics. ‘We focus on a system’, explained Cristina, ‘for us, the guidelines are 
there and what is more important is to be able to operationalise those 
guidelines’. Through the enrolment of quality control models and standard 
operating procedures, ethical review can be described, assessed and evidenced. 
This activity, in the language of FERCAP, is referred to as The Survey.  
[58] Checking and measuring ethical review processes, The Survey focuses on 
and con- tinues the ‘profound shift’ of ethics as a form of audit, as distinct from 
an ethics rooted in the professional.  
Auditing the audit  
The Survey, as conducted by volunteer members of FERCAP, measures the 
work of ethical review committees against standards drawn up by a working 
group of SIDCER, who met in Olympia, Washington in September 2005 to 
create what is now known as the Recognition Program (SIDCER 2005). 
FERCAP’s Survey implements these stan- dards, marshalling logics of audit to 
answer the problem perceived by clinical trial sponsors and capacity builders 
alike: how do you know that an ethics review commit- tee conducts a ‘good’ 
review?  
The SIDCER Recognition Program is accompanied by a statement that its stan- 
dards provide the international community with ‘a way to measure and provide 
accountability regarding the quality and effectiveness of ethical review 
worldwide’ (Karbwang Laothavorn 2011: 11). As Jacob and Riles note, ‘[o]ne 
of the interesting fea- tures of modern ethics is that it must continually be 
demonstrated – it must be bureau- cratically evidenced, revealed, documented, 
enacted, performed’ (2007: 181). The authors of the SIDCER standards 
included directors of quality assurance, internal au- ditors, quality assurance 
analysts, directors of regulatory affairs, and though the major- ity were from 
the USA, the group included members from eight different countries. The 
standards were designed without reference to specific national laws or 
guidelines, in order to be internationally applicable. FERCAP is therefore able 
to use them across the ten countries where it works to assess how ethics 
committees operate, what their assessment criteria are, and how they document 
and follow-up proposals. However, as Merry remarks, such devices reveal ‘a 
slippage between the political and the techni- cal’, as measures are always 
‘rooted in particular conceptions of problems and theories of responsibility’ 
(2011: S88). Hence, the theory of responsibility that shifted the gov- ernance of 
medical research from the professions to external review gives rise to a new 
problem: how to govern the resulting ethics committees?  
The Survey is where the theories of responsibility (and accountability) built 
into this mode of governing are reinterpreted. While the activities that 
FERCAP surveys would be recognisable to a biomedical or clinical auditor, the 
way they are carried out might not be. During research, I took part in these 
activities as an observer-trainee, learning the ropes of surveying in three 
countries, and discussing future or recent sur- veys in two more. A committee 
initiates the recognition process by conducting a Self- Assessment, measuring 
their committee against a checklist of requirements. The survey that follows 
this is a three-day event, during which a survey team of four to six mem- bers, 
plus up to 10 local trainees, reviews the reviews made by the committee under 
study. The survey team selects cases, scrutinises the files and minutes, and 
examines the continuing review practices of the committee. Survey team 
members interview committee members, and observe a meeting at which the 
committee reviews a protocol. The amount of work is vast, but the tone is one 
of (sometimes strained) conviviality. Unlike an audit process, which might 
position itself ‘as an increasingly private and invisible expert activity’ (Power 
1994: 26), FERCAP’s work is conducted at a point where hospitality meets 
audit (Douglas-Jones 2012a). The enterprise is founded on a [59] principle of 
mutual investment: the surveyed may become surveyors in turn, and all 
surveyors have themselves at some point been surveyed. The standards 
surveyors hold others to are standards they are held to themselves. Survey days 
are long, often lasting 12 hours or more. Vast amounts of (excellent) food are 
eaten. There will be time taken for meals out together, and for seeing sights: 
historic buildings, parks, museums and palaces. Surveyors are drawn from 
other parts of the network: international surveyors lend ‘objectivity’ to the 
review (Hamadian and Johansen 2010; Douglas-Jones 2012a), while local 
surveyors provide knowledge of national laws, and sometimes translation. The 
team are invited – as guests – by the committee under review, and emphasise 
that they come ‘as friends’, to learn and to improve both the committee and 
themselves. Surveyors receive no remuneration for their work and participants 
– surveyors and sur- veyed – are often actually friends, spending long hours 
together poring over docu- ments, training others, receiving and giving tours of 
offices, making presentations with suggestions for improvements. Doing 
criticism well is difficult, even if one is an invited guest, and the model 
developed by FERCAP poses questions about the extent to which this is 
governing-at-a-distance, and about the strange bedfellows made by col- 
laboration and competition (Douglas-Jones 2012a). FERCAP’s Survey 
practices are thus a fusion of a monitoring gaze and a mutualistic, 
developmental ethos. This begs the question: where is the ‘relationship of 
power between scrutinizer and observed’ (Foucault 1977: 200) on which 
assessment and judgement appear to live? Rather than submitting to being 
‘objects of information’, surveyed committees remain subjects in 
communication (1977: 200), part subject to, and part conversation partners in 
the mu- tual establishment and maintenance of SIDCER standards. Through 
these standards, FERCAP measures how well a committee conforms, and 
recognises those which do, awarding them a certificate and a cut-glass trophy 
at the annual November conference. The rapidly growing Recognition Program 
has assessed more than 120 committees.  
One might ask: why has the Recognition Program been so successful? Since 
the process is entirely voluntary, why do committees submit themselves to 
evaluation? Are there alternatives? When FERCAP presents its program of 
‘recognition’ to pro- spective member committees, it begins by describing an 
international research arena in which ensuring the quality of research is 
paramount. The idea of ‘harmonisation’ of research protocols, standards and 
formats across regulatory regimes, which assisted the uptake of Good Clinical 
Practice (International Conference on Harmonisation 2010; Holden and 
Demeritt 2008), is extended from protocols and mechanisms of data reporting 
to ethical review procedures: their alignment ensures trial results are accept- 
able to regulatory bodies such as the United States Food and Drug 
Administration (USFDA). Participation in the Recognition Program may help 
committees to attract in- ternational research in the future: their name will be 
listed on the FERCAP website, and the ethics committee may display 
FERCAP’s logo on its own website. Sponsors of research are invoked: 
‘sponsors’, committees are told, ‘would like to have assurance that the Ethics 
Committee is compliant with Good Clinical Practice (GCP). If it is not, it 
becomes GCP deviation, a violation’, which can threaten the acceptability of 
trial data for regulators. While ‘local’ ethics committees are necessary for 
sponsors, their members also desire the research that a recognised ethics 
committee might bring. Adopting an internationally recognised form of 
governance, even though it is not a reg- ulatory requirement, is suddenly 
appealing to committees and their institutes for the potential ticket it offers to a 
global marketplace of trials. As Kipnis would put it, ‘seeing like a governing 
agent in a complex industrial society makes audit an attractive tool’ [60]  
(2008: 286). This statement also applies to committees as governed agents 
themselves. The responsibility for compliance has shifted ‘to the monitored 
organisation, corpora- tion or country itself’ (Merry 2011: S88).  
As FERCAP and its activities have grown over the last decade, questions of its 
le- gitimacy have been raised. If it aims to perform ‘rituals of verification’ 
(Power 1997: 1, quoting Douglas 1992), then what rituals count, and whose 
truth comes to matter? These questions fit with the broader contestation over 
epistemic authority seen in this issue: who should set standards, and how do 
global rankers gain their positions? In what ways does the growth of non-
governmental organisations intersect with the growth of ranking and indicators 
beyond the nation state (Shore and Wright, this issue; Keck and Sikkink 1998; 
Irwin 2008; Merry 2011)? During my research, researchers, committee 
members and representatives of Departments of Health across the region asked 
FERCAP about whether its activities could amount to ‘accreditation’, felt by 
many to be an activity that only a state had the authority to bestow. The orga- 
nisation responded by emphasising that its project was one of ‘recognition’, not 
‘accreditation’, the former involving supportive capacity building and a 
developmen- tal, voluntary agenda. The number of committees voluntarily 
submitting themselves to the process, they argued, was evidence enough of the 
need for its supportive and constructive work.  
In both its friendliness and seriousness, the Survey rests in the shadowy 
anticipa- tion that European and American drug regulatory authorities will 
sometimes begin an ‘actual’ audit of sites in Asia for ‘compliance’, opening a 
space of ethical review per- ceived as out of reach to trial sponsor auditors and 
national drug regulators (Hamadian and Johansen 2010). During my research, 
an American organisation AAHRPP (the Association for the Accreditation of 
Human Research Protection Programs Inc.), which explicitly ‘accredits’ ethics 
review committees, was beginning to make inroads into what they viewed as 
the ‘Asian market’, accrediting a committee in Singapore, as well as 
committees in China, India, Taiwan and South Korea. In their own language, 
‘AAHRPP’s accreditation standards are becoming the standards of choice 
around the globe’, and for the US-based company, international accreditations 
serve as ‘a reminder that we truly can have one standard for research 
protections worldwide’ (AAHRPP 2012). Leaving aside the universalising 
ambitions of the form (rather than content) of this mode of doing ethics, what 
does the presence of AAHRPP make visible?  
Since FERCAP describes its work as ‘grassroots’ and ‘bottom up’, the contrast 
its members make with AAHRPP’s accreditation process is helpful. While 
discussing his committee’s recognition by FERCAP, Bill, a researcher who 
served on an ethics com- mittee in Taiwan, commented that FERCAP was a 
foundation project, that its inten- tion was to ‘build capacity, help build up 
from ground zero’, whereas AAHRPP was ‘already at the top floor of that 
skyscraper, the sign of the qualified’. Speaking of his experiences in Taiwan, 
he commented that ‘now that almost all the committees in Taiwan have been 
recognised by FERCAP, some are trying to shift to AAHRPP. Now that has 
become the gold standard’. Bill felt that if one committee got AAHRPP 
accreditation, others felt pressure to get it:  
We like competition. If you were independent, and I have AAHRPP or 
FERCAP and you don’t have, people will think your Ethics Committee not 
good enough, so that’s the reason why we have to get more and more. [61] 
Bill’s statement reflects a logic that I saw repeatedly in my interviews, which I 
tried to unpick with the question ‘good enough for what?’ Bill’s reply was, 
‘For our thinking, we can say “I’ve got an international recognition, you know 
I’m an international level.”’ And why was this important, I asked? ‘For fame!’ 
he exclaimed. It was not just the opinion of others driving committees and their 
members. Bill himself felt a strong sense of pride. ‘I know how it feels’, he 
said. The prospect of acquiring AAHRPP’s ‘gold seal’ was also appealing to 
recognised committees for reasons of ‘continuing improvement’. As one 
secretary, whose committee was on its way to six years of recognition, put it: 
‘In my way, I think our committee is just beginning, it is not yet mature.’ 
Similarly, in Pune, India, at the Jehangir Clinical Development Centre, CEO 
Pathik Divate said of his committee’s recent AAHRPP accreditation:  
We viewed [it] as the logical step to take our program to the next level – for re- 
search participation, standardization and quality. We’ve also sent a message to 
the rest of the research institutes [...] If they’re serious about clinical research, 
they should be thinking about AAHRPP accreditation. (AAHRPP 2012)  
The Survey appears to be set up along utilitarian lines, affirming the need for 
eth- ical review to audit biomedical research, and relying on standards to 
produce a second order audit that reviews the review process. However, its 
mutualistic, capacity-building orientation distinguishes it from AAHRPP, as do 
the claims it makes on ethics committee members’ professionalism, as I 
explore below.  
Audit to professionals  
FERCAP is clearly a measuring organisation, and one of the outcomes of its 
‘capacity building’ is that committees become known to themselves, to one 
another and to exter- nal others such as sponsors of clinical trials. While 
FERCAP has no ranked classes of recognition, or ‘top 10’ committees, it is 
itself ranked by some of its members as sec- ondary to the US-based AAHRPP. 
It also provides a measure by which countries can pit themselves against one 
another by comparing the number of committees recognised: Bhutan has 1, 
China 44; Taiwan has 23, South Korean 28, and informal competitions arise as 
a result of recognition as enumeration. But what kinds of subjects is FERCAP 
geared towards producing? How do people navigate ‘interrelations among [its] 
written plans, official pronouncements, off the record comments and observed 
so- cial practice’ (Kipnis 2008: 285)? One might imagine that alongside this 
structured au- dit-like recognition of committees, individual exam-based 
qualifications would also be available, contributing to an ongoing growth in 
credentialing and accreditation (Brown and Bills 2011). Indeed, credentialing 
of individuals is a large and lucrative industry for ethical review in the USA 
through the CIP, the Certified IRB Professional program. Developed by the 
Boston-based Public Responsibility in Medicine and Research (PRIM&R) in 
1999, this credentialing of individuals to sit on ethics committees (known in the 
USA as Institutional Review Boards, or IRBs) was something FERCAP 
attempted to emulate in 2008 with their ‘Certification for Ethics in Research 
Profi- ciency’, or CERP. Cheaper, available in local languages, and not based 
solely on US documents, policies and legislation, it was intended to be a way to 
support and mark out the new ethics professionals. It was not at all successful: 
as one interviewee [62] recounted for a preliminary meeting in Taipei, Taiwan, 
‘nobody wanted to take it ... there were more speakers than audience!’ This low 
uptake was repeated across the dif- ferent sites where FERCAP works. I 
suggest it reveals a different relationship between the bundle of techniques of 
governance known as audit, and the idea of the profes- sional. There are ‘IRB 
professionals’ in certain parts of the world, most prominently the USA, for 
whom reviewing proposals and running review is their job. For most of 
FERCAP’s members across Asia, however, these roles are voluntary, on top of 
existing duties as practising clinicians, lawyers and researchers. This makes the 
invoca- tion of ‘the professions’ both more interesting and more complicated. 
While FERCAP’s survey work is a network of nascent ethics professionals 
supporting one another in building committees and writing standard operation 
procedures, it is also a network of biomedical researchers, since many ethics 
committee members are practis- ing clinicians themselves. Thus the kind of 
recommendations for how committee mem- bers should be and behave was not 
aimed at carving out a separate profession. There was something far more 
interesting going on.  
With their understanding of how committees ‘work’ across the region, 
FERCAP’s project with ethics committees began to specify, implicitly, the 
kinds of skills and atti- tudes deemed part of building ‘capacity’ in ethical 
review. At a pre-conference training I attended in Chiang Mai, Thailand in 
2009, held in a side room of the Imperial Mae Ping Hotel, about 60 people 
from across the region had convened. They were there to discuss the qualities 
and responsibilities of the two parties most directly implicated in the 
management of ethical review committees: Secretaries and Chairpersons. The 
format focused on the presentation of personal experiences, and drew out 
qualities of ‘integrity and moral rectitude’ in the committee members beyond 
their formal ‘role’ on the committee. During this session, for example, a 
Chairperson was described as someone who ‘cannot tell people to be ethical if 
he or she is not ethical’; a Chairperson ‘cannot be having an affair. If you are 
unfaithful to your wife, how can you be faithful to the review process?’  
This commensurability between personal and professional ethics is not the 
professionalisation of ‘best practice, training standards and public 
responsibilities’ de- scribed by medical anthropologist Kleinman (2010) in 
contemporary China. Nor is it a ‘loop through which professionals demonstrate 
(to other professionals) their adher- ence to standards’ (Strathern 2000: 292). 
FERCAP’s professional is also not immedi- ately recognisable as the ‘self 
managing individual’ who ‘renders themselves auditable’ (Shore and Wright 
2000: 57). It is perhaps not even best described as ‘profes- sionalism’ in the 
classic Weberian sense of separating the institutional role from the self. Rather 
than developing a fully-fledged persona as ethics professionals, FERCAP 
mem- bers are encouraged to understand ethics through a personal 
transformation. In this they resemble perhaps more closely the ‘romantic’ 
rather than the ‘utilitarian’ ethic of Pels’s argument (2000). They were 
supported in taking up a ‘duty’-based ethics that is compatible, in the words of 
FERCAP’s coordinator, with ‘the East Asian setting that is clearly steeped in 
the Confucian tradition of beneficent governance and grounded in the Buddhist 
principle of selflessness’ (Torres 2011: 48).  
I also observed counter narratives to regulation through ethical review in 
stories that narrated committee members’ own attitudinal shifts. One member 
told me that her involvement with ethical review began when she volunteered. 
‘It was in me al- ready’, she said, ‘being involved in IRBs just made it come 
out stronger.’ Similarly, during a Good Clinical Practice session in Bangkok, I 
had been discussing with a Thai [63] committee member, Cathy, the difficulties 
her committee had experienced in implementing ‘standardisation’. Cathy 
pointed out something she thought I hadn’t quite grasped, as I struggled to 
reconcile the priorities presented in the training. ‘No rule can write it all’, she 
said simply. ‘Regulators cannot do what integrity and the culture of a faculty 
can do.’ She hoped people would first recognise that rules exist, and then 
attend courses to learn more about doing research well, but ethics would only 
be effective, she thought, when people ‘become ethical not just in their rules 
but in their life and mind’, in a dialogical engagement beyond individualism 
(Laidlaw 2013). Such an attitude fits poorly with calculation, even if it 
resonates clearly with self-management and responsibilisation. Since those who 
run ethical review commit- tees are themselves biomedical researchers, 
FERCAP hopes they will in turn convey these transformed attitudes to their 
colleagues and fellow researchers at their institutions.  
The mismatch between regulation and ‘integrity’ that Cathy pointed to 
highlights a tension that surfaced at the organisation’s annual conferences in 
2010 and 2011 (Douglas-Jones 2012b). Medical and institutional frustrations 
with proceduralised ethics have, in the USA, given rise to a renaissance of the 
idea of the professional, de- spite ongoing reference in trainings to the failures 
of professional ethics and the back- drop of research scandals from which 
‘external’ ethical review draws its legitimacy (Taylor 2007). In 2004, medical 
researchers in Canada drew on William Sullivan’s research to support their 
view that ‘[n]either economic incentives nor technology nor administrative 
control has proved an effective surrogate for the commitment to integrity 
evoked in the ideal of professionalism’ (Sullivan 1995: 16, cited in Cruess et al. 
2002). This statement emerged from decades of experimentation with ethical 
review and associated accreditation in North America, where complaints are 
raised that ‘there is little direct, measurable evidence that the heightened 
burden [of review] actually increases the effectiveness of protecting human 
subjects, or improves the quality of the research itself’ (Koski 2011). At the 
FERCAP annual conferences, the absence of ‘evidence’ for the effectiveness of 
ethical review actually brings something else to the fore:  
[W]e simply have to say, ‘All right, we’re really talking about integrity, 
integrity is what we’re falling back on in hope that that’s what is actually going 
to protect human subjects’ [...] Not a committee, not regulations. (Koski 2011: 
np)  
The intersection of interest in ‘integrity’ between members of FERCAP and 
American medical researchers is, I suggest, not coincidental, but care must be 
taken in reading the significance and implications of the overlap.  
Conclusion  
Building on Pels’ arguments for the status of ethics in anthropology, I suggest 
that what FERCAP struggles to hold steady is the relationship between a 
romantic ethic, in which people act on principles, and a utilitarian ethic, now 
bundled into review pro- cesses, procedures and second-order audits that come 
to operate as rankings. Within this latter utilitarian framework, which FERCAP 
advances and supports, something that resembles Pels’ romantic ethic seems to 
re-emerge in the face of dissatisfaction with [64] ethics-as-audit. North 
American advocacy for a return to governance through the pro- fessions and 
professionalism is reaching FERCAP’s conferences (Douglas-Jones 2012b), 
yet these conferences themselves exist because of review, a practice that 
emerges from the assumption that locating ethics in the professions was not 
enough (Wilson 2011). When FERCAP members articulate their interest in 
personal and pro- fessional integrity, when they take their involvement with 
ethics as a way of living and reject the figure of the credentialised IRB 
professional, they nonetheless still do so within the framework of a desire for 
recognition, and of regional competition for clin- ical trials. The ethical 
professional selves they invoke may reference familiar ideals of legibility or 
self-management, but also other disciplined and cultivated characteristics such 
as duty, filiality or faithfulness (see also Kipnis 2011). This is not therefore a 
story of inevitability, or of a ‘global’ form (such as ethical review) assimilating 
‘local’ envi- ronments of research practice and governance (Collier and Ong 
2005: 11).  
Mechanisms of research ethics are a historically specific response to the kinds 
of public scandals that left the idea of professional integrity empty and 
inadequate as a moderator of medical research. Ethics committees themselves 
developed out of crises in the contract between biomedicine and the state 
(Hedgecoe 2009; Wilson 2011 for the UK; Stark 2012 for the USA), emerging 
at a time when mechanisms of accountabil- ity looked like audit processes. 
This article demonstrates how the legacies of such forms of governance, which 
have been worked into the operation of the clinical trials industry, are evident 
in the expansion of clinical trial infrastructure into Asia. With bio- medical 
research come ethics committees, and with ethics committees come FERCAP’s 
second-order reviews. As an anticipatory mode of governance, such review 
makes its assessments prior to anything taking place (Strathern 2000: 295; 
Amit 1996). One might also say that the establishment of ethics committees in 
some of FERCAP’s participating countries is itself anticipatory. Many 
committees that participate in FERCAP’s Recog- nition Program are intensely 
proud of what they see as their initiative, having neither been forced into being 
by public scandals or government pressure, nor otherwise obli- gated to seek 
FERCAP’s recognition or AAHRPP’s accreditation. This voluntarism itself has 
effects: the measure and recognition of FERCAP does not function as a 
national indicator, and is not in the hands of any government, even if it 
functions as an indicator that committee members themselves use to compare 
nations. The (often hard won) cut glass trophies that sit in ethics committee 
offices across Asia, denoting Survey recognition, represent prestige within a 
growing economy of accreditation for ethical review. I have therefore sought to 
make visible this tussle over what counts as ethics, a topic of increasing 
concern to anthropologically inclined minds (Lambek 2010; Laidlaw 2013). In 
this paper, the question plays out through the simultaneous de- sire of my 
interviewees for utilitarian accreditation and romantic professionals with in- 
tegrity. FERCAP’s work challenges what it means to do a ‘good’ ethical 
review, and how this current form of doing ethics in biomedical research is 
itself to be recognised as ethical.  
 
1  Research ethics committee or just ethics committee (EC) is the shorthand used most 
frequently in FERCAP’s presentations; IRB is used more by American commentators and 
countries that orient their ethics review procedures towards the American model. In this text, I 
refer to ethics committees.   
2  ESRC Grant Number RES-062-23-0215.   
3 This argument nods to Stark’s acute observation that ethics committees, or in her US 
context, IRBs, ‘are consequential because they affect how researchers go about creating 
knowledge – and, as a result, the kinds of things that are knowable’ (2011: 234).  
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